Infectious Diseases

Featured Article
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for care access, and how they foresee this new indication…
Is AI the Future for COVID-19 Screening?
“For people to get back to a near-normal life, gathering in larger numbers, we will need a system of screening that is non-invasive–and provides an effective first-line of defense,” says Shady Hassan…
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test…

Newsfeed

Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Is AI the Future for COVID-19 Screening?
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
Pharmacy Interns and Inactive Pharmacists to Deliver Vaccines: ASHP Reacts to Recent HHS Guidance
A Year Into Pandemic, Federal Officials Move to Better Protect Frontline Workers
Phase 3 Study to Examine Humanized Monoclonal Antibody as COVID-19 Treatment
The Gender Vaccine Gap: More Women Than Men Are Getting COVID-19 Shots
Mass Vaccination Sites: How Pharmacists Can Ensure Accountability While Preventing Waste and Loss
View More

Insights

Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for…
Is AI the Future for COVID-19 Screening?
“For people to get back to a near-normal life, gathering in larger numbers, we will need a system of screening that is non-invasive–and provides an effective first-line of defense,” says Shady Hassan, MD, co-founder, chief medical officer and chief…
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed test…
Pharmacy Interns and Inactive Pharmacists to Deliver Vaccines: ASHP Reacts to Recent HHS Guidance
Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows inactive pharmacists along with pharmacy interns to join the vaccinator force—explaining that as the…
View More

Interactive Features

Reducing Hospitalizations for OAs Over 65 Years of Age in NHs
Gregg Sylvester, MD, MPH, chief medical officer, Seqirus, explains why the use of Fluad (Influenza Vaccine, Adjuvanted) was more effective than non-adjuvanted standard dose trivalent influenza vaccine for reducing the risk of all-cause…
Reviewing New COVID Vaccine Data and the Effect on Accessibility
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson…
Ad Council Aims to Help Providers Better Understand Questions Expected About COVID-19 Vaccinations
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,…
ASHP Expert Talks Vaccine Hesitancy, New Challenges Following COVID-19 Vaccine Rollout
Anna Legreid Dopp, PharmD, senior director of clinical guidelines and quality improvement, ASHP, provides the need-to-know details of the COVID-19 vaccine, including how the vaccine rollout will impact the everyday work of a pharmacist as well as…
View More
Back to Top